相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。IL-21 enhances STAT3/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis
Yanan Xu et al.
IMMUNOLOGIC RESEARCH (2021)
New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
Ruksana Huda
FRONTIERS IN IMMUNOLOGY (2020)
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo et al.
GENES (2020)
HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells
Jing Li et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
Role of Natural Products in Modulating Histone Deacetylases in Cancer
Myriam Merarchi et al.
MOLECULES (2019)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus
Eun Wha Choi et al.
SCIENTIFIC REPORTS (2018)
Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model
Lei Sun et al.
LIFE SCIENCE ALLIANCE (2018)
Myasthenia gravis: the role of complement at the neuromuscular junction
James F. Howard
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab
Dagur Ingi Jonsson et al.
NEUROMUSCULAR DISORDERS (2017)
High-dose BAFF receptor specific mAb-siRNA conjugate generates Fas-expressing B cells in lymph nodes and high-affinity serum autoantibody in a myasthenia mouse model
Naazneen Ibtehaj et al.
CLINICAL IMMUNOLOGY (2017)
Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis
Cun-Jin Zhang et al.
JOURNAL OF IMMUNOLOGY (2016)
Myasthenia gravis - autoantibody characteristics and their implications for therapy
Nils Erik Gilhus et al.
NATURE REVIEWS NEUROLOGY (2016)
Histone H4 lysine 20 acetylation is associated with gene repression in human cells
Jun-Ya Kaimori et al.
SCIENTIFIC REPORTS (2016)
IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice
Ruksana Huda et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
Vuslat Yilmaz et al.
PLOS ONE (2015)
IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis
Marie Maurer et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4+ T Cell Polarization in Vitro and in Vivo
Rainer Glauben et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy
Silvia Consalvi et al.
EPIGENOMICS (2014)
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
Aleksander M. Grabiec et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis
Revital Aricha et al.
JOURNAL OF AUTOIMMUNITY (2011)
Complement and cytokine based therapeutic strategies in myasthenia gravis
Erdem Tuezuen et al.
JOURNAL OF AUTOIMMUNITY (2011)
HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis
Jelena Vojinovic et al.
MOLECULAR MEDICINE (2011)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells
Oliver Dienz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Histone hyperacetylation is associated with amelioration of experimental colitis in mice
Rainer Glauben et al.
JOURNAL OF IMMUNOLOGY (2006)
Acetylation and deacetylation of non-histone proteins
MA Glozak et al.
GENE (2005)
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
S Camelo et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Pathophysiology of myasthenia gravis
BW Hughes et al.
SEMINARS IN NEUROLOGY (2004)
Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production
CS Deng et al.
JOURNAL OF IMMUNOLOGY (2002)
Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression
JW Li et al.
GENES & DEVELOPMENT (2002)